Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica.

The research article discusses the variances or “polymorphism” observed on the lipopolysaccharides (LPS) from different strains of Bordetella bronchiseptica, a type of bacterium that affects both humans and animals. The study utilized monoclonal antibodies and found four types of antigenic changes in the LPSs of B. bronchiseptica, raising prospects for further understanding of the bacterium and development of treatments.

Antigenic Polymorphism Examination

• The researchers used six different monoclonal antibodies, substances produced in a lab to act against specific cells or proteins. These antibodies were targeted against LPS on different strains of Bordetella bacteria: pertussis or whooping cough, parapertussis or mild whooping cough, and bronchiseptica.
• The study focused on examining B. bronchiseptica strains from 48 different clinical isolates. These isolates were traced back to various host organisms – humans, dogs, horses, pigs, and rabbits.
• The goal was to investigate the presence of specific antigenic determinants – parts of an antigen that cause an immune response – of LPS on B. bronchiseptica cells.

Findings and Observations

• Significant cross-reactivity, which refers to the degree to which different antigens appear similar to the immune system, were observed between the B. bronchiseptica and the other Bordetella strains.
• Among the tested strains, there were noticeable antigenic differences or “polymorphism”. The strains could be grouped into six different immune-related categories.
• The researchers used various analytical procedures including ELISA (a test that measures immune responses in the blood), thin-layer chromatography, and tricine-SDS-PAGE (a process used for protein separation) to analyze individual purified LPS extracts.
• Through this analysis, four major types of antigenic variances in B. bronchiseptica LPSs were identified: differences in the core of the bacteria, presence or absence of O-chains (a part of the LPS structure), differences in the hinge region between the core and O-chain, and the way LPS interacts with other cell surface constituents.

Implications of Findings

• ‘Smooth-type’ LPS molecules, which can be identified using the monoclonal antibody PP6, were more commonly found in animal isolates of the bacteria (94%) compared to human isolates (52%).
• On the other hand, monoclonal antibody 60.5, which does not react with long-chain LPSs, was more frequently found in human isolates (48%) than in animal isolates (18%).
• The researchers propose that these differences may be due to the lack of certain receptors in humans, specifically in the bronchoalveolar tissues or the sections of the lung that facilitate the exchange of gases.
• The results obtained in this study can help in understanding the evolution, adaptation, and immune evasion strategies of B. bronchiseptica. They also offer valuable insights for the design of effective treatments and vaccines against the bacterium.